Interested in elevating your vitality with hormonal supplements? Discover safe and legal Testosterone Gel options for sale in AU. Find top-quality hormone balance solutions, carefully curated to suit ...

Please provide your email address to receive an email when new articles are posted on . In a randomized double blind, placebo-controlled trial with older men assigned either AndroGel 1% (transdermal ...

If you’re not a fan of needles, testosterone cream offers an easy, needle-free way to treat low testosterone. Just rub the topical testosterone replacement therapy (TRT) right onto your skin. It helps ...

Upsher-Smith Laboratories announced it has received final approval from the FDA for its New Drug Application (NDA) for Vogelxo (testosterone) gel for topical use. Vogelxo is a Schedule CIII androgen ...

Endo Pharmaceuticals Receives FDA Approval for FORTESTA(TM) (Testosterone) Gel as a Class III Product for Topical Use for Men with Low Testosterone FORTESTA Gel is the first approved testosterone ...

Compared with exercise alone, combining exercise training with testosterone gel application did not result in longer 6-minute walk distances (6MWDs) in older women with a recent hip fracture repair ...

May 7, 2009 — The US Food and Drug Administration (FDA) held a press conference today to announce a change in the labeling of the testosterone gel products AndroGel 1% (Solvay Pharmaceuticals) and ...

Are you a male experiencing symptoms of low testosterone such as weight gain and a high-pitched voice? If so, you may want to look into a product by the name of AndroGel. This testosterone gel has ...

Active ingredient: Testosterone 10 mg/0.5 g actuation; metered-dose pump; topical gel. Indication: Primary hypogonadism. Hypogonadotropic hypogonadism. Pharmacology: Fortesta is a topical gel ...

San Francisco, Calif. and Torrance, Calif. (June 20, 2002) – A Phase 3 study conducted at multiple research centers in the U.S. under the direction of Ronald Swerdloff, MD, Principal Investigator at ...

LINCOLNSHIRE, Ill.--(BUSINESS WIRE)-- BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced that a New Drug Application (NDA) has been accepted for filing by the U.S. Food and Drug ...